You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023214015
Dec 20234107
Jan 20243001
Feb 20245601
Mar 20242408
Apr 20242605
May 20242402
Jun 20242001
Jul 20243603
Aug 20241401
Sep 20242402
Oct 20241006
Nov 20242602
Dec 20241208
Jan 20252807
Feb 2025003
Mar 2025003
Apr 2025002
May 2025004
Jun 2025004
Total585085